AzTrials
AzTrials

Suicide AttemptAPSOMNCT03427190

Suicide Prevention Algorithm in the French Overseas Territories

A study of Suicide Attempt, run by University Hospital Center of Martinique at 9 sites in 4 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In France, suicide behaviours are a major public health concern that triggered the creation in 2013 of a National Observatory of Suicide. In continental France, the "Algos" protocol was found to be effective for the prevention of suicide attempts reiterations. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Suicide Attempt
Could I receive a placebo?
No, everyone receives an active treatment
How many people
259 participants
Where
9 sitesin 4 countries
Study dates
9 Oct 2017to 16 Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Man or woman over 16 years of age
  • Leaving the hospital within 15 days of the suicide attempt
  • Giving (him/herself or his/her legal representative)an oral consent to participate in the study
  • Having healthcare insurance
  • Reachable by phone, with possibility of confidential conversation, and by mail
  • Resident of Guadeloupe, French Guyana, Martinique, or Reunion Island
  • Able to understand and speak French

Who cannot join

  • Homeless person
  • Disabled adult, person under judicial/court protection, legally incompetent adult
  • Participant unable to understand the study protocol, its risks and side effects, or declining to participate

Trial locations and contacts

9 sites in 4 countries.

9 sites in 4 countries

Reunion4 sites
  • Etablissement Psychiatrique de Santé Mentale

    Saint-Benoît, 97470

  • Centre d'Accueil Psychiatrique Nord

    Saint-Denis, 97405

  • Centre d'Accueil Psychiatrique Ouest-Centre

    Saint-Paul, 97863

  • Centre d'Accueil d'Urgences Médico-Psychologique

    Saint-Pierre, 97448

Other trials in Reunion

French Guiana2 sites
  • CH de Cayenne

    Cayenne, 97306

  • CH Ouest Guyanais

    Saint-Laurent-du-Maroni, 97393

Other trials in French Guiana

Guadeloupe2 sites
  • CHU de Pointe à Pitre

    Les Abymes, 97189

  • CH de Monteran

    Saint-Claude, 97120

Other trials in Guadeloupe

Martinique1 site
  • CHU Martinique

    Fort-de-France, 97261

Other trials in Martinique

About this study

Official title: Assessment of Preventive Efficacy of an Algorithm Taking Place After Suicide Attempts Among Attempters Admitted to Hospital in the French Overseas Territories

In France, suicide behaviours are a major public health concern that triggered the creation in 2013 of a National Observatory of Suicide. In continental France, the "Algos" protocol was found to be effective for the prevention of suicide attempts reiterations. This protocol is based on a procedure that keeps telephone and postal contacts with the suicide attempter and allows, via an algorithm, to assess the risk of suicide attempt recurrence, in order to intervene if necessary. Nevertheless, Algos does not involve primary care health practitioners, who could add a substantial additional efficacy, especially if they intervene downstream and in supplement to Algos. In addition, this kind of protocol has never been evaluated in the French overseas territories.

Read the detailed description

Since (1) Algos was never implemented in the French overseas departments (FOD) and does not involve primary care practitioners (PCP), (2) the additional effect of PCP involvement over and beyond Algos alone in unknown, and (3) little research on suicide behaviours has been conducted in the FOD, this proposal has the following main aim: to assess the effectiveness and the efficacy of the intervention, in supplement and downstream to Algos, of a healthcare professional, on the recurrence of suicide attempts in the FOD; the healthcare professional will be the patient's general practitioner, whenever possible.

Conditions
Suicide Attempt
Being tested
APSOM vs Control
Keywords
Suicide, Suicide attempted, Secondary Prevention, Relapse prevention, Case Management, Intervention Study
Medical subject headings
Suicide, Attempted, Suicide

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • APSOM vs ControlOther

    In complement to actions described in the control arm, the patient's general practitioner (GP) and the patient him/herself will be contacted within 21 days of hospital discharge in order to organize an appointment between them two; this consultation is expected to take place between day 22 and day 45 after hospital discharge. If the patient does not have a GP, a health-care professional (HCP) will be provided. .GP (or HCP) will also be contacted at 6 and 13 months.

Study groups in NCT03427190
Study groupRoleWhat they receive
ControlActive comparatorPhone contact with patient will be made by a professional psychologist within 21 days of hospital discharge. If contact cannot be made after 9 attempts, post-cards will be sent monthly at M2, M3, M4 and M5, asking the participant to establish contact with the designated psychologist. The phone call will determine whether or not the participant is in a state of suicidal crisis. If yes, steps will be taken to attend the crisis within 24 hours.
Receives: Other: APSOM vs Control
APSOMOtherIn complement to actions described in the control arm, the patient's general practitioner (GP) and the patient him/herself will be contacted within 21 days of hospital discharge in order to organize an appointment between them two; this consultation is expected to take place between day 22 and day 45 after hospital discharge. If the patient does not have a GP, a health-care professional (HCP) will be provided. .GP (or HCP) will also be contacted at 6 and 13 months.
Receives: Other: APSOM vs Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Existence of a suicide

    Reiteration of suicidal attempt after hospital discharge

    Measured: 6 months

  2. Existence of a suicide

    Reiteration of suicidal attempt after hospital discharge

    Measured: 13 months

Secondary outcomes (4)
  1. Number of suicide attempts

    To know total number of suicide

    Measured: 6 and 13 months after hospital discharge

  2. Number of deaths by suicide

    To know number of deaths by suicide

    Measured: 6 and 13 months after hospital discharge

  3. Scores at the Hospital Anxiety and Depression Scale (HADS)

    Pass the scale HADS

    Measured: 6 and 13 months after hospital discharge

  4. Assessment of suicidal risk by the Sad Persons Scale and the Columbia Suicide Severity Rating Scale (C-SSRS).

    Pass the scale Columbia

    Measured: 6 and 13 months after hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2018
  2. Study start9 Oct 2017
  3. Primary completion8 Aug 2019
  4. Study completion16 Oct 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
259 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03427190
Sponsor's protocol ID
15/B/04
Acronym
APSOM
Status last verified
Oct 2020
First submitted
30 Jan 2017
Last updated
28 Jan 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.

    PubMed 33884617

Questions about this trial

What is this clinical trial studying?

A study of Suicide Attempt, run by University Hospital Center of Martinique at 9 sites in 4 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in Reunion, French Guiana, Guadeloupe, Martinique. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Existence of a suicide (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03427190, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in